Immunocore stock holds at USD 32.18 as earnings remain mixed

Published on 09/23/2026 at 04:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Immunocore stock opened at USD 32.18 on September 22, 2026, while its 52-week range was USD 27.56 to USD 40.71. Q2 EPS missed estimates.

IMCR, GB00BL963Z95, Illustration mit AI erstellt.

Immunocore Holdings plc (GB00BL963Z95) opened at USD 32.18 on Nasdaq on September 22, 2026. The quote stood within a 52-week range of USD 27.56 to USD 40.71, leaving the stock USD 8.53 below its yearly high and USD 4.62 above its yearly low.

Earnings remain the key test

According to MarketBeat on September 22, 2026, Immunocore reported a loss of USD 0.02 per share for the quarter ended before the report dated August 7, 2026, compared with a consensus loss estimate of USD 0.01 per share. The USD 0.01 shortfall keeps profitability at the center of the valuation debate.

The same report states that Immunocore posted a negative net margin of 4.20 percent and negative return on equity of 4.54 percent for the reported period. Those figures contrast with the analyst projection of USD 0.06 earnings per share for the full year, making the path from quarterly loss to annual profitability the main operating comparison.

Analysts see upside but risk remains

MarketBeat reported on September 22, 2026, that the average 12-month price target among brokerages covering the stock was USD 56.375. The report also cited an overweight rating with a USD 50.00 target, while the latest opening price of USD 32.18 was USD 24.195 below the average target.

The numerical gap is substantial, but the latest quarterly miss supplies a counterweight. A projected full-year EPS of USD 0.06 depends on a change from the reported quarterly loss of USD 0.02 per share, so future updates on revenue conversion and operating costs remain material to the investment case.

Stock stays below yearly high

At USD 32.18 on September 22, 2026, Immunocore stock was 21.0 percent below its 52-week high of USD 40.71 and 16.8 percent above its low of USD 27.56. The market data and the earnings comparison point in different directions: the share price remains well above the yearly floor, while quarterly profitability has not yet matched expectations.